Manufacturer Supply with High Purity and Stable Quality
Trelagliptin Succinate (CAS: 1029877-94-8) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7
| Chemical Name | 2-Cyano-5-Flurobenzyl Bromide |
| Synonyms | 2-(Bromomethyl)-4-Fluorobenzonitrile |
| CAS Number | 421552-12-7 |
| CAT Number | RF-PI143 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C8H5BrFN |
| Molecular Weight | 214.03 |
| Melting Point | 67.0 to 71.0℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White to Off-Yellow Powder |
| Purity / Analysis Method | ≥98.0% (HPLC) |
| Moisture (K.F) | ≤0.50% |
| Test Standard | Enterprise Standard |
| Usage | Trelagliptin Succinate (CAS: 1029877-94-8) Intermediate; Organic Synthesis |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis.
2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) can be used in the synthesis of Trelagliptin Succinate (CAS: 1029877-94-8).
Trelagliptin Succinate (CAS: 1029877-94-8) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent. Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. Trelagliptin Succinate has a long duration of action and is well tolerated in clinical studies. Trelagliptin (as the salt Trelagliptin succinate) was approved for use in Japan in March 2015. Takeda, the company that developed Trelagliptin, chose to not get approval for the drug in the USA and EU.